GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curachem Co Ltd (XKRX:456190) » Definitions » Debt-to-EBITDA

Curachem Co (XKRX:456190) Debt-to-EBITDA : 0.00 (As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is Curachem Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Curachem Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₩0.00 Mil. Curachem Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₩0.00 Mil. Curachem Co's annualized EBITDA for the quarter that ended in . 20 was ₩0.00 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Curachem Co's Debt-to-EBITDA or its related term are showing as below:

XKRX:456190's Debt-to-EBITDA is not ranked *
in the Biotechnology industry.
Industry Median: 1.42
* Ranked among companies with meaningful Debt-to-EBITDA only.

Curachem Co Debt-to-EBITDA Historical Data

The historical data trend for Curachem Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curachem Co Debt-to-EBITDA Chart

Curachem Co Annual Data
Trend
Debt-to-EBITDA

Curachem Co Semi-Annual Data
Debt-to-EBITDA

Competitive Comparison of Curachem Co's Debt-to-EBITDA

For the Biotechnology subindustry, Curachem Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curachem Co's Debt-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curachem Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Curachem Co's Debt-to-EBITDA falls into.



Curachem Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Curachem Co's Debt-to-EBITDA for the fiscal year that ended in . 20 is calculated as

Curachem Co's annualized Debt-to-EBITDA for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (. 20) EBITDA data.


Curachem Co  (XKRX:456190) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Curachem Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Curachem Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Curachem Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
207, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Chungcheongbuk-do, Cheongju-si, KOR, 28161
Curachem Co Ltd is a manufacturing lab of radiolabeled compounds. Its main products include radiolabeled compounds used for in vivo absorption, distribution, metabolism, and excretion (ADME) studies, Phase I mass balance and micro-dosing (phase 0 and enhanced Phase I) research, and various works in a production facility, such as manufacturing, quality control, and quality assurance.

Curachem Co Headlines

No Headlines